Biogen Inc.
DE ˙ DB ˙ US09062X1037
170,90 € ↑8,70 (5,36%)
2026-06-04
AKTIENPREIS
SecurityDE:IDP / Biogen Inc.
InstitutionIMC-Chicago, LLC
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
IMC-Chicago, LLC ownership in IDP / Biogen Inc.

On May 5, 2026 - IMC-Chicago, LLC filed a 13F-HR form disclosing ownership of 0 shares of Biogen Inc. (DE:IDP) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 19,011 shares of Biogen Inc.. The current value of the position is $0 USD.

IMC-Chicago, LLC has a history of taking positions in derivatives of the underlying security (IDP) in the form of stock options. The firm currently holds call options representing 147,700 of underlying shares valued at $27,077,841 USD and put options representing 162,300 of underlying shares valued at $29,754,459 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:IDP / Biogen Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F BIOGEN COM 09062X103 0 -100.00 0
2026-01-29 2025-12-31 13F BIOGEN COM 09062X103 19,011 19,011 3,346 0.0012
2022-04-19 2022-03-31 13F BIOGEN COM 09062X103 0 -10,222 -100.00 0 -100.00
2022-02-08 2021-12-31 13F BIOGEN COM 09062X103 10,222 -1,243 -10.84 2,452 -24.41 0.0020
2021-11-05 2021-09-30 13F BIOGEN COM 09062X103 11,465 -12,940 -53.02 3,244 -61.61 0.0034
2021-08-06 2021-06-30 13F BIOGEN COM 09062X103 24,405 24,405 8,451 0.0104
2021-05-14 2021-03-31 13F BIOGEN COM 09062X103 0 -11,998 -100.00 0 -100.00
2021-02-17 2020-12-31 13F BIOGEN COM 09062X103 11,998 11,998 2,938 0.0038
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-05 2026-03-31 13F BIOGEN COM Call 147,700 11.56 27,078 16.21 n/a n/a n/a
2026-01-29 2025-12-31 13F BIOGEN COM Call 132,400 19.28 23,301 49.86 n/a n/a n/a
2025-11-04 2025-09-30 13F BIOGEN COM Call 111,000 8.82 15,549 21.37 n/a n/a n/a
2025-07-22 2025-06-30 13F BIOGEN COM Call 102,000 20.14 12,810 10.27 n/a n/a n/a
2025-04-14 2025-03-31 13F BIOGEN COM Call 84,900 236.90 11,618 201.51 n/a n/a n/a
2025-01-27 2024-12-31 13F BIOGEN COM Call 25,200 36.22 3,854 7.45 n/a n/a n/a
2024-10-25 2024-09-30 13F BIOGEN COM Call 18,500 12.80 3,586 -5.66 n/a n/a n/a
2024-07-15 2024-06-30 13F BIOGEN COM Call 16,400 11.56 3,802 19.94 n/a n/a n/a
2024-04-12 2024-03-31 13F BIOGEN COM Call 14,700 -54.77 3,170 -62.32 n/a n/a n/a
2024-02-09 2023-12-31 13F BIOGEN COM Call 32,500 4.84 8,410 5.56 n/a n/a n/a
2023-10-12 2023-09-30 13F BIOGEN COM Call 31,000 -0.32 7,967 -10.06 n/a n/a n/a
2023-07-14 2023-06-30 13F BIOGEN COM Call 31,100 -29.00 8,859 -27.26 n/a n/a n/a
2023-04-24 2023-03-31 13F BIOGEN COM Call 43,800 -65.86 12,178 -65.73 n/a n/a n/a
2023-04-24 2022-12-31 13F/A BIOGEN COM Call 128,300 -34.41 35,529 -31.97 n/a n/a n/a
2023-02-09 2022-12-31 13F BIOGEN COM Call 128,300 36 n/a n/a n/a
2022-11-08 2022-09-30 13F BIOGEN COM Call 195,600 167.21 52,225 249.85 n/a n/a n/a
2022-08-05 2022-06-30 13F BIOGEN COM Call 73,200 200.00 14,928 190.48 n/a n/a n/a
2022-04-19 2022-03-31 13F BIOGEN COM Call 24,400 -74.69 5,139 -77.78 n/a n/a n/a
2022-02-08 2021-12-31 13F BIOGEN COM Call 96,400 -16.61 23,128 -29.30 n/a n/a n/a
2021-11-05 2021-09-30 13F BIOGEN COM Call 115,600 -32.83 32,714 -45.10 n/a n/a n/a
2021-08-06 2021-06-30 13F BIOGEN COM Call 172,100 157.25 59,593 218.42 n/a n/a n/a
2021-05-14 2021-03-31 13F BIOGEN COM Call 66,900 -78.99 18,715 -76.00 n/a n/a n/a
2021-02-17 2020-12-31 13F BIOGEN COM Call 318,400 421.11 77,963 349.80 n/a n/a n/a
2020-11-17 2020-09-30 13F BIOGEN COM Call 61,100 -33.37 17,333 -29.35 n/a n/a n/a
2020-08-14 2020-06-30 13F BIOGEN COM Call 91,700 164.27 24,534 123.48 n/a n/a n/a
2020-05-14 2020-03-31 13F BIOGEN COM Call 34,700 -57.58 10,978 -54.77 n/a n/a n/a
2020-02-13 2019-12-31 13F BIOGEN COM Call 81,800 49.54 24,273 90.60 n/a n/a n/a
2019-11-12 2019-09-30 13F BIOGEN COM Call 54,700 -24.03 12,735 -24.37 n/a n/a n/a
2019-08-15 2019-06-30 13F BIOGEN COM Call 72,000 -63.19 16,839 -63.58 n/a n/a n/a
2019-05-15 2019-03-31 13F BIOGEN COM Call 195,600 908.25 46,236 691.98 n/a n/a n/a
2019-04-24 2018-12-31 13F BIOGEN COM Call 19,400 5,838 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-05 2026-03-31 13F BIOGEN COM Put 162,300 42.74 29,754 48.70 n/a n/a n/a
2026-01-29 2025-12-31 13F BIOGEN COM Put 113,700 95.70 20,010 145.88 n/a n/a n/a
2025-11-04 2025-09-30 13F BIOGEN COM Put 58,100 33.26 8,139 48.64 n/a n/a n/a
2025-07-22 2025-06-30 13F BIOGEN COM Put 43,600 -7.23 5,476 -14.87 n/a n/a n/a
2025-04-14 2025-03-31 13F BIOGEN COM Put 47,000 6,431 n/a n/a n/a
2024-07-15 2024-06-30 13F BIOGEN COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-04-12 2024-03-31 13F BIOGEN COM Put 11,300 -44.61 2,437 -53.85 n/a n/a n/a
2024-02-09 2023-12-31 13F BIOGEN COM Put 20,400 72.88 5,279 74.08 n/a n/a n/a
2023-10-12 2023-09-30 13F BIOGEN COM Put 11,800 -34.81 3,033 -41.18 n/a n/a n/a
2023-07-14 2023-06-30 13F BIOGEN COM Put 18,100 -67.74 5,156 -66.95 n/a n/a n/a
2023-04-24 2023-03-31 13F BIOGEN COM Put 56,100 -36.39 15,597 -36.14 n/a n/a n/a
2023-04-24 2022-12-31 13F/A BIOGEN COM Put 88,200 -78.14 24,424 -77.32 n/a n/a n/a
2023-02-09 2022-12-31 13F BIOGEN COM Put 88,200 24 n/a n/a n/a
2022-11-08 2022-09-30 13F BIOGEN COM Put 403,400 862.77 107,708 1,160.48 n/a n/a n/a
2022-08-05 2022-06-30 13F BIOGEN COM Put 41,900 138.07 8,545 130.51 n/a n/a n/a
2022-04-19 2022-03-31 13F BIOGEN COM Put 17,600 -86.14 3,707 -87.83 n/a n/a n/a
2022-02-08 2021-12-31 13F BIOGEN COM Put 127,000 -9.87 30,470 -23.58 n/a n/a n/a
2021-11-05 2021-09-30 13F BIOGEN COM Put 140,900 -41.73 39,873 -52.38 n/a n/a n/a
2021-08-06 2021-06-30 13F BIOGEN COM Put 241,800 357.95 83,728 466.84 n/a n/a n/a
2021-05-14 2021-03-31 13F BIOGEN COM Put 52,800 -62.82 14,771 -57.52 n/a n/a n/a
2021-02-17 2020-12-31 13F BIOGEN COM Put 142,000 88.58 34,770 62.77 n/a n/a n/a
2020-11-17 2020-09-30 13F BIOGEN COM Put 75,300 25.50 21,361 33.07 n/a n/a n/a
2020-08-14 2020-06-30 13F BIOGEN COM Put 60,000 72.91 16,053 46.23 n/a n/a n/a
2020-05-14 2020-03-31 13F BIOGEN COM Put 34,700 -53.49 10,978 -50.41 n/a n/a n/a
2020-02-13 2019-12-31 13F BIOGEN COM Put 74,600 69.55 22,136 116.09 n/a n/a n/a
2019-11-12 2019-09-30 13F BIOGEN COM Put 44,000 -9.09 10,244 -9.50 n/a n/a n/a
2019-08-15 2019-06-30 13F BIOGEN COM Put 48,400 -8.33 11,319 -9.31 n/a n/a n/a
2019-05-15 2019-03-31 13F BIOGEN COM Put 52,800 64.49 12,481 29.20 n/a n/a n/a
2019-04-24 2018-12-31 13F BIOGEN COM Put 32,100 9,660 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.